CHALKIS(SZ:000972) Xin Lang Cai Jing·2025-10-27 11:03Core Viewpoint - *ST Zhongji reported a significant decline in net profit for the first three quarters of 2025, despite an increase in revenue, indicating potential financial distress and operational challenges [1][2]. Financial Performance - The company's revenue for the first three quarters of 2025 was 354 million yuan, representing an 18.92% year-on-year increase [1]. - The net profit attributable to shareholders was -144 million yuan, a decrease of 230.90% year-on-year [1]. - The non-recurring net profit attributable to shareholders was -207 million yuan, down 348.55% year-on-year [1]. - Basic earnings per share were -0.19 yuan [2]. Profitability Metrics - The gross margin for the first three quarters of 2025 was -6.93%, a decline of 20.90 percentage points year-on-year [2]. - The net margin was -42.63%, down 28.22 percentage points compared to the same period last year [2]. - In Q3 2025, the gross margin was -14.06%, a year-on-year decrease of 12.48 percentage points [2]. - The net margin for Q3 2025 was -67.59%, which increased by 37.24 percentage points year-on-year [2]. Expense Analysis - Total operating expenses for the period were 104 million yuan, an increase of 51.08 million yuan year-on-year [2]. - The expense ratio was 29.41%, up 11.59 percentage points from the previous year [2]. - Sales expenses decreased by 39.26%, while management expenses surged by 190.14% [2]. - R&D expenses fell by 55.18%, and financial expenses rose by 60.30% [2]. Shareholder Information - As of the end of Q3 2025, the total number of shareholders was 25,500, an increase of 233 from the end of the previous half [2]. - The average market value of shares held per shareholder rose from 108,500 yuan to 109,600 yuan, reflecting a 1.04% increase [2]. Company Overview - Zhongji Health Industry Co., Ltd. is located in Wujiaqu City, Xinjiang, and was established on June 30, 1994, with its stock listed on September 26, 2000 [3]. - The company's main business involves the production and deep processing of tomato products, with the primary revenue sources being bulk raw sauce (88.37%), lycopene (5.77%), and other products [3]. - The company is classified under the agricultural and forestry industry, specifically in the processing of fruits and vegetables [3].